Investigator Global assessment (IGA) of Actinic Keratosis (AK) among patients administered tirbanibulin in real-world community practices across the U.S., and clinician likelihood to consider tirbanibulin again for future AK treatments (PROAK Study). (2023). SKIN The Journal of Cutaneous Medicine, 7(2), s162. https://doi.org/10.25251/skin.7.supp.162